Drug Type Small molecule drug |
Synonyms SPN 821, SPN821 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Depressive Disorder, Major | Phase 2 | United States | 19 Jan 2026 | |
| Depressive Disorder, Treatment-Resistant | Phase 1 | - | - |





